{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-050025","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2026-11-05T02:38:11+00:00","discovered_at":"2026-11-05T11:05:00.305043+00:00","generated_at":"2026-11-05T11:05:38.730061+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bioxytran secures attested Free Sale Certificate for A-SUQAR, targeting UAE and Gulf markets","bullets":["A-SUQAR received a government-issued Free Sale Certificate, legalized by the issuing country's Ministry of Foreign Affairs and prepared for attestation for UAE use.","Certificate confirms A-SUQAR is lawfully manufactured and freely sold as a food and health supplement; Bioxytran plans UAE product registration with its distribution partner.","Bioxytran will evaluate registration pathways in Saudi Arabia, Kuwait and other GCC markets; launch timing depends on completion of local regulatory requirements.","A-SUQAR is a pre-meal chewable tablet using polysaccharides to slow intestinal carbohydrate enzymes; it is regulated as a U.S. dietary supplement, not an FDA-approved drug.","Release cites about 7.5M adults with diabetes across UAE, Saudi Arabia and Kuwait; UAE prevalence 20.7%, Saudi 23.1%, Kuwait 25.6% (IDF 2025)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-050025","json":"https://secwatch.observer/filing/0001493152-26-050025.json","markdown":"https://secwatch.observer/filing/0001493152-26-050025.md","text":"https://secwatch.observer/filing/0001493152-26-050025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226050025/0001493152-26-050025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315226050025/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-05T11:05:38.730061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}